Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MIMEDX to Participate in Upcoming Investor Conferences
-
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
-
BairesDev Named a 2024 Power Partner Award Winner by Inc.
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
4BIO Capital Strengthens Investment Team
-
Notice on Convocation of Extraordinary General Meeting of Shareholders of AB “KN Energies”
-
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
-
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
-
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval
-
Regenx Announces Facility Update
-
Bitget Wallet Lite Hits 6 Million Users in Days, Now The Largest Telegram Wallet
-
Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan
-
FTI Consulting Expands Financial Services Practice with Appointment of Two Senior Managing Directors
-
Aveanna Healthcare Holdings Announces Appointment of New Director
-
Apogee Therapeutics to Participate in Upcoming November Investor Conferences
-
Altimmune to Report Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
-
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
-
ZenaTech Announces Dual Listing of Its Shares on the Frankfurt Stock Exchange
-
Legend Biotech Appoints Alan Bash as President of CARVYKTI®
-
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement
-
Skyharbour Enters into Agreements to Partner with Hatchet Uranium Corp. on Several of its Uranium Projects Located in the Athabasca Basin, Saskatchewan
-
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
-
Editas Medicine Announces Third Quarter 2024 Results and Business Updates
-
SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
-
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
-
Abeona Therapeutics® Announces Participation in November Investor Conferences
-
Finance Expert Shinobu Hindert Leads Financial Literacy Workshop in Kenya to Empower Young Women
-
Incyclix Bio Announces Abstract Accepted for Presentation at 2024 San Antonio Breast Cancer Symposium
-
ElevateBio Appoints Amy Pooler, Ph.D., as Senior Vice President, Research and Development
-
Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board
-
Trading by management and close relations of management
-
Keynode Introduces Innovative Free Crypto Staking Plan, Empowering Users to Earn Passive Income
-
Form 8.3 - [ECKOH PLC - 01 11 2024] - (CGWL)
-
Ward Village® Welcomes Residents to Victoria Place® as Newest Residential Tower Opens in Acclaimed Howard Hughes Community in Honolulu
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia
-
Kraig Biocraft Laboratories Announces Successful Completion of Latest Recombinant Spider Silk Production Batch
-
Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors
-
Capital Southwest Announces Proposed Convertible Notes Offering
-
Tether Launches Holiday Gift Guide for Cannabis Retailers Across Ontario
-
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
-
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
-
AMG Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2024
-
Arvinas to Participate in Upcoming Investor Conferences
-
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
-
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
-
Kforce Inc. Announces Participation in the UBS Global Technology and AI Conference
-
Kamada to Present at the Stifel 2024 Healthcare Conference

